Advertisement

AIDS and Behavior

, Volume 22, Issue 5, pp 1584–1595 | Cite as

Psychological Factors Associated With Painful Versus Non-Painful HIV-Associated Sensory Neuropathy

  • Prinisha Pillay
  • Antonia L. Wadley
  • Catherine L. Cherry
  • Alan S. Karstaedt
  • Peter R. Kamerman
Original Paper

Abstract

HIV-associated sensory neuropathy (HIV-SN) is a common, and frequently painful complication of HIV, but factors that determine the presence of pain are unresolved. We investigated: (i) if psychological factors associated with painful (n = 125) versus non-painful HIV-SN (n = 72), and (ii) if pain and psychological factors affected quality of life (QoL). We assessed anxiety and depression using the Hopkins Symptoms Checklist-25. Pain catastrophizing and QoL were assessed using the Pain Catastrophizing Scale and Euroqol-5D, respectively. Presence of neuropathy was detected using the Brief Neuropathy Screening Tool, and pain was characterised using the Wisconsin Brief Pain Questionnaire. Overall, there was a high burden of pain, depression and anxiety in the cohort. None of the psychological variables associated with having painful HIV-SN. Greater depressive symptoms and presence of pain were independently associated with lower QoL. In those participants with painful HIV-SN, greater depressive symptom scores were associated with increased pain intensity. In conclusion, in a cohort with high background levels of psychological dysfunction, psychological factors do not predict the presence of pain, but both depression and presence of pain are associated with poor quality of life.

Keywords

Depression Pain intensity Quality of life Painful HIV-associated sensory neuropathy 

Notes

Acknowledgements

The authors wish to thank the patients and staff of the Greenhouse Pharmacy at the Chris-Hani Baragwanath Hospital, and Florence Mtsweni for acting as an interpreter in the study. They are also grateful for the assistance of Mr. Rashid Adam from the Greenhouse Pharmacy. The authors gratefully acknowledge the contribution to this work of the Victorian Operational Infrastructure Support Program received by the Burnet Institute (CLC), the Medical Research Council (MRC) and the TATA Foundation for Doctoral funding (PP) and the Hillel Friedland Trust for Fellowship funding (AW).

Funding

Medical Faculty Research Endowment Fund of the University of the Witwatersrand (PP), Medical Research Council of South Africa (PRK), National Research Foundation Rated Researchers Programme (PRK), Victorian Operational Infrastructure Support Program received by the Burnet Institute (CLC), and Developed-Developing Countries Collaborative Research Grant of the International Association for the Study of Pain (CLC, PRK).

Compliance with Ethical Standards

Conflict of interest

All authors (PP, ALW, CLC, ASK and PRK) declare no conflict of interest.

Ethical Approval

All procedures performed in the study were in accordance with the ethical standards of the Wits Human Research Ethics Committee (Medical) and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

Informed Consent

Written informed consent was obtained from all individual participants included in the study.

Supplementary material

10461_2017_1856_MOESM1_ESM.pdf (83 kb)
Supplementary material 1 (PDF 83 kb)
10461_2017_1856_MOESM2_ESM.docx (20 kb)
Supplementary material 2 (DOCX 20 kb)
10461_2017_1856_MOESM3_ESM.docx (15 kb)
Supplementary material 3 (DOCX 14 kb)
10461_2017_1856_MOESM4_ESM.docx (14 kb)
Supplementary material 4 (DOCX 14 kb)
10461_2017_1856_MOESM5_ESM.docx (14 kb)
Supplementary material 5 (DOCX 14 kb)
10461_2017_1856_MOESM6_ESM.docx (17 kb)
Supplementary material 6 (DOCX 17 kb)

References

  1. 1.
    Kamerman PR, Wadley AL, Cherry CL. HIV-associated sensory neuropathy: risk factors and genetics. Curr Pain Headache Rep. 2012;16(3):226–36.PubMedCrossRefGoogle Scholar
  2. 2.
    Mehta SA, Ahmed A, Laverty M, Holzman RS, Valentine F, Sivapalasingam S. Sex differences in the incidence of peripheral neuropathy among Kenyans initiating antiretroviral therapy. Clin Infect Dis. 2011;53(5):490–6.PubMedPubMedCentralCrossRefGoogle Scholar
  3. 3.
    Arenas-Pinto A, Thompson J, Musoro G, et al. Peripheral neuropathy in HIV patients in sub-Saharan Africa failing first-line therapy and the response to second-line ART in the EARNEST trial. J Neurovirol. 2015;22(1):104–13.PubMedCrossRefGoogle Scholar
  4. 4.
    Kamerman PR. HIV neuropathy: down but not out. Figshare. 2016;. doi: 10.6084/m9.figshare.2656255.Google Scholar
  5. 5.
    Ellis RJ, Rosario D, Clifford DB, et al. Continued high prevalence and adverse clinical impact of human immunodeficiency virus-associated sensory neuropathy in the era of combination antiretroviral therapy: the CHARTER Study. Arch Neurol. 2010;67(5):552–8.PubMedPubMedCentralCrossRefGoogle Scholar
  6. 6.
    Evans SR, Ellis RJ, Chen H, et al. Peripheral neuropathy in HIV: prevalence and risk factors. AIDS. 2011;25(7):919–28.PubMedPubMedCentralCrossRefGoogle Scholar
  7. 7.
    Lee AJ, Bosch RJ, Evans SR, et al. Patterns of peripheral neuropathy in ART-na??ve patients initiating modern ART regimen. J Neurovirol. 2015;21(2):210–8.PubMedPubMedCentralCrossRefGoogle Scholar
  8. 8.
    Hendry LM, Wadley AL, Cherry CL, Price P, Lombard Z, Kamerman PR. TNF block gene variants associated with pain intensity in Black Southern Africans with HIV-associated sensory neuropathy. Clin J Pain. 2015;32(1):45–50.CrossRefGoogle Scholar
  9. 9.
    Hendry L, Lombard Z, Wadley A, Kamerman P. KCNS1, but not GCH1, is associated with pain intensity in a black southern African population with HIV-associated sensory neuropathy: a genetic association study. J Acquir Immune Defic Syndr. 2013;63(1):27–30.PubMedCrossRefGoogle Scholar
  10. 10.
    Wadley AL, Hendry LM, Kamerman PR, et al. Role of TNF block genetic variants in HIV-associated sensory neuropathy in black Southern Africans. Eur J Hum Genet. 2013;2014(27):1–6.Google Scholar
  11. 11.
    Wadley AL, Mitchell D, Kamerman PR. Resilience does not explain the dissociation between chronic pain and physical activity in South Africans living with HIV. PeerJ. 2016;4:e2464.PubMedPubMedCentralCrossRefGoogle Scholar
  12. 12.
    Cherry CL, Wadley AL, Kamerman PR. Painful HIV-associated sensory neuropathy. Pain Manag. 2012;2(6):543–52.PubMedCrossRefGoogle Scholar
  13. 13.
    Phillips TJC, Brown M, Ramirez JD, et al. Sensory, psychological, and metabolic dysfunction in HIV-associated peripheral neuropathy: a cross-sectional deep profiling study. Pain. 2014;155(9):1846–60.PubMedPubMedCentralCrossRefGoogle Scholar
  14. 14.
    Maritz J, Benatar M, Dave J, et al. HIV neuropathy in South Africans: frequency, characteristics, and risk factors. Muscle Nerve. 2010;41(5):599–606.PubMedGoogle Scholar
  15. 15.
    Smyth K, Affandi JS, Mcarthur JC, et al. Prevalence of and risk factors for HIV-associated neuropathy in Melbourne, Australia 1993–2006. HIV Med. 2007;8(6):367–73.PubMedCrossRefGoogle Scholar
  16. 16.
    Wadley AL, Cherry CL, Price P, Kamerman PR. HIV neuropathy risk factors and symptom characterization in stavudine-exposed South Africans. J Pain Symptom Manag. 2011;41(4):700–6.CrossRefGoogle Scholar
  17. 17.
    Simpson DM, Haidich A-B, Schifitto G, et al. Severity of HIV-associated neuropathy is associated with plasma HIV-1 RNA levels. AIDS. 2002;16(3):407–12.PubMedCrossRefGoogle Scholar
  18. 18.
    Polydefkis M, Yiannoutsos CT, Cohen B, et al. Reduced intraepidermal nerve fiber density in HIV-associated sensory neuropathy. Neurology. 2002;58(1):115–9.PubMedCrossRefGoogle Scholar
  19. 19.
    Zhou L, Kitch DW, Evans SR, et al. Correlates of epidermal nerve fiber densities in HIV-associated distal sensory polyneuropathy. Neurology. 2007;68(24):2113–9.PubMedCrossRefGoogle Scholar
  20. 20.
    Martina C, Solders G, Sönnerborg A, Hansson P. Painful and non-painful neuropathy in HIV-infected patients: an analysis of somatosensory nerve function. Eur J Pain. 2003;7(1):23–31.CrossRefGoogle Scholar
  21. 21.
    McWilliams LA, Goodwin RD, Cox BJ. Depression and anxiety associated with three pain conditions: results from a nationally representative sample. Pain. 2004;111(1–2):77–83.PubMedCrossRefGoogle Scholar
  22. 22.
    Wertli MM, Rasmussen-Barr E, Held U, Weiser S, Bachmann LM, Brunner F. Fear-avoidance beliefs-a moderator of treatment efficacy in patients with low back pain: a systematic review. Spine J. 2014;14(11):2658–78.PubMedCrossRefGoogle Scholar
  23. 23.
    Lucey BP, Clifford DB, Creighton J, Edwards RR, McArthur JC, Haythornthwaite J. Relationship of depression and catastrophizing to pain, disability, and medication adherence in patients with HIV-associated sensory neuropathy. AIDS Care. 2011;23(8):921–8.PubMedPubMedCentralCrossRefGoogle Scholar
  24. 24.
    Malvar J, Vaida F, Sanders CF, et al. Predictors of new onset distal neuropathic pain in HIV-infected individuals in the era of combination antiretroviral therapy. Pain. 2015;156:731.PubMedPubMedCentralCrossRefGoogle Scholar
  25. 25.
    Keltner JR, Vaida F, Ellis RJ, et al. Health-related quality of life “well-being” in HIV distal neuropathic pain is more strongly associated with depression severity than with pain intensity. Psychosomatics. 2012;53(4):380–6.PubMedPubMedCentralCrossRefGoogle Scholar
  26. 26.
    Van Sighem A, Gras L, Reiss P, Brinkman K, De Wolf F. Life expectancy of recently diagnosed asymptomatic HIV-infected patients approaches that of uninfected individuals. Wolters Kluwer Heal AIDS. 2010;24:1527–35.Google Scholar
  27. 27.
    Mills EJ, Bakanda C, Birungi J, et al. Life expectancy of persons receiving combination antiretroviral therapy in low-income countries: a cohort analysis from Uganda. Ann Intern Med. 2011;155(4):209–17.PubMedCrossRefGoogle Scholar
  28. 28.
    Clifford DB, Simpson DM, Brown S, et al. A randomized, double-blind, controlled study of NGX-4010, a capsaicin 8% dermal patch, for the treatment of painful HIV-associated distal sensory polyneuropathy. J Acquir Immune Defic Syndr. 2012;59(2):126–33.PubMedCrossRefGoogle Scholar
  29. 29.
    Phillips TJC, Cherry CL, Cox S, Marshall SJ, Rice ASC. Pharmacological treatment of painful HIV-associated sensory neuropathy: a systematic review and meta-analysis of randomised controlled trials. PLoS One. 2010;5(12):e14433.PubMedPubMedCentralCrossRefGoogle Scholar
  30. 30.
    Folstein MF, Folstein SE, McHugh PR. Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12(3):189–98.PubMedCrossRefGoogle Scholar
  31. 31.
    Cherry CL, Wesselingh SL, Lal L, McArthur JC. Evaluation of a clinical screening tool for HIV-associated sensory neuropathies. Neurology. 2005;65(11):1778–81.PubMedCrossRefGoogle Scholar
  32. 32.
    Singleton JR, Bixby B, Russell JW, et al. The Utah Early Neuropathy Scale: a sensitive clinical scale for early sensory predominant neuropathy. J Peripher Nerv Syst. 2008;13(3):218–27.PubMedCrossRefGoogle Scholar
  33. 33.
    MAPI. Mapi Research Institute.Linguistic validation process. http://www.mapi-institute.com Accessed 19 May 2011.
  34. 34.
    Ganasen KA, Fincham D, Smit J, Seedat S, Stein D. Utility of the HIV Dementia Scale (HDS) in identifying HIV dementia in a South African sample. J Neurol Sci. 2008;269(1–2):62–4.PubMedCrossRefGoogle Scholar
  35. 35.
    Roos A, Calata D, Jonkers L, et al. Normative data for the Tygerberg cognitive battery and mini-mental status examination in a South African population. Compr Psychiatr. 2010;51(2):207–16.CrossRefGoogle Scholar
  36. 36.
    Sullivan M, Bishop S, Pivik J. The pain catastrophizing scale: development and validation. Psychol Assess. 1995;7(4):524–32.CrossRefGoogle Scholar
  37. 37.
    McDonald RP. Test theory: A unified treatment. Test theory A unified Treat. 1999:485.Google Scholar
  38. 38.
    Brooks R. EuroQol: the current state of play. Health Policy. 1996;37(1):53–72.PubMedCrossRefGoogle Scholar
  39. 39.
    The_EuroQol_Group. EuroQol–a new facility for the measurement of health-related quality of life. The EuroQol Group. Health Policy. 1990;16(3):199–208.CrossRefGoogle Scholar
  40. 40.
    Derogatis LR, Lipman RS, Rickels K, Uhlenhuth EH, Covi L. The Hopkins Symptom Checklist (HSCL): a self-report symptom inventory. Behav Sci. 1974;19(1):1–15.PubMedCrossRefGoogle Scholar
  41. 41.
    Kagee A, Martin L. Symptoms of depression and anxiety among a sample of South African patients living with HIV. AIDS Care. 2010;22(2):159–65.PubMedCrossRefGoogle Scholar
  42. 42.
    Daut RL, Cleeland CS, Flanery RC. Development of the Wisconsin brief pain questionnaire to assess pain in cancer and other diseases. Pain. 1983;17(2):197–210.PubMedCrossRefGoogle Scholar
  43. 43.
    Mphahlele N, Mitchell D, Kamerman P. Validation of the Wisconsin brief pain questionnaire in a multilingual South African population. J Pain Symptom Manag. 2008;36(4):396–412.CrossRefGoogle Scholar
  44. 44.
    Hung CF, Gibson SA, Letendre SL, et al. Impact of long-term treatment with neurotoxic dideoxynucleoside antiretrovirals: implications for clinical care in resource-limited settings. HIV Med. 2008;9(9):731–7.PubMedPubMedCentralCrossRefGoogle Scholar
  45. 45.
    Polydefkis MJ. Peripheral neuropathy and HIV. Hopkins HIV Rep. 2002;14:6.PubMedGoogle Scholar
  46. 46.
    R Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria; 2014 http://www.R-project.org/.
  47. 47.
    Kamil Barto’n. MuMIn: Multi-model inference. R package version 1.10.5. 2014. http://CRAN.R-project.org/package=MuMIn.
  48. 48.
    Frank E Harrell Jr. rms: Regression ModelingStrategies.R package version 4.2-1. 2014 http://CRAN.R-project.org/package=rms.
  49. 49.
    Kamerman PR, Wadley AL, Pillay P. Data and analysis scripts: psychological factors associated with painful vs. non-painful HIV-associated sensory neuropathy. Pain. 2017;. doi: 10.6084/m9.figshare.4555474.Google Scholar
  50. 50.
    Latremoliere A, Woolf CJ. Central sensitization: a generator of pain hypersensitivity by central neural plasticity. J Pain. 2009;10(9):895–926.PubMedPubMedCentralCrossRefGoogle Scholar
  51. 51.
    Uebelacker LA, Bailey GL. Chronic pain in HIV-infected patients: relationship to depression, substance use, and mental health and pain treatment. Pain Med. 2015;16:1870–81.PubMedPubMedCentralCrossRefGoogle Scholar
  52. 52.
    Thom, RMG. Depression and Anxiety in HIV infected individuals attending HIV treatment facilities at various sites in South Africa: Occurence and related factors. A descriptive-analytic study. 2008 wiredspace.wits.ac.za/bitstream/handle/10539/6939/.Google Scholar
  53. 53.
    Jonsson G, Furin J, Jeenah F, et al. Human rights, mental illness, and HIV: the Luthando Neropsychiatric HIV Clinic in Soweto, South Africa. Health Hum Rights. 2011;13(2):E64–72.PubMedGoogle Scholar
  54. 54.
    Freeman M, Nkomo N, Kafaar Z, Kelly K. Mental Disorder in People Living with HIV/Aids in South Africa. South African J Psychol. 2008;38(3):489–500.CrossRefGoogle Scholar
  55. 55.
    Blackburn-Munro G, Blackburn-Munro RE. Chronic pain, chronic stress and depression: coincidence or consequence? J Neuroendocrinol. 2001;13(12):1009–23.PubMedCrossRefGoogle Scholar
  56. 56.
    Dworkin RH, Gitlin MJ. Clinical aspects of depression in chronic pain patients. Clin J Pain. 1991;7(2):79–94.PubMedCrossRefGoogle Scholar
  57. 57.
    Holmes A, Christelis N, Arnold C. Depression and chronic pain. Med J Aust. 2013;199(6):S17–20.PubMedGoogle Scholar
  58. 58.
    Mwesiga EK, Mugenyi L, Nakasujja N, Moore S, Kaddumukasa M, Sajatovic M. Depression with pain co morbidity effect on quality of life among HIV positive patients in Uganda: a cross sectional study. Health Qual Life Outcomes. 2015;13(1):206.PubMedPubMedCentralCrossRefGoogle Scholar
  59. 59.
    Miaskowski C, Penko JM, Guzman D, Mattson JE, Bangsberg DR, Kushel MB. Occurrence and characteristics of chronic pain in a community-based cohort of indigent adults living with HIV infection. J Pain. 2011;12(9):1004–16.PubMedPubMedCentralCrossRefGoogle Scholar
  60. 60.
    Richardson JL, Heikes B, Karim R, Weber K, Anastos K, Young M. Experience of pain among women with advanced HIV disease. AIDS Pat Care STDS. 2009;23(7):503–11.CrossRefGoogle Scholar
  61. 61.
    Ossipov MH, Morimura K, Porreca F. Descending pain modulation and chronification of pain. Curr Opin Support Palliat Care. 2014;8(2):143–51.PubMedPubMedCentralGoogle Scholar
  62. 62.
    Quartana PJ, Campbell CM, Edwards RR. Pain catastrophizing: a critical review. Expert Rev Neurother. 2009;9(5):745–58.PubMedPubMedCentralCrossRefGoogle Scholar
  63. 63.
    Finnerup NB, Attal N, Haroutounian S, et al. Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. Lancet Neurol. 2015;14(2):162–73.PubMedPubMedCentralCrossRefGoogle Scholar
  64. 64.
    Ballantyne JC, Sullivan MD. Intensity of chronic pain—the wrong metric? N Engl J Med. 2015;373(22):2098–9.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2017

Authors and Affiliations

  1. 1.Brain Function Research Group, School of Physiology, Faculty of Health SciencesUniversity of the WitwatersrandJohannesburgSouth Africa
  2. 2.International Clinical Research Laboratory, Centre for Biomedical ResearchBurnet InstituteMelbourneAustralia
  3. 3.Department of Infectious DiseasesAlfred Hospital and Monash UniversityMelbourneAustralia
  4. 4.Department of MedicineChris Hani Baragwanath HospitalJohannesburgSouth Africa
  5. 5.School of Biomedical Sciences, Faculty of Health SciencesCurtin UniversityPerthAustralia

Personalised recommendations